Reply to letter to the editor in response to 'A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose' by Montenegro S et al (JOGOH-D-23-00756).
暂无分享,去创建一个
[1] M. Grynberg,et al. Comparative effectiveness of gonadotropins used for ovarian stimulation during assisted reproductive technologies (ART) in France: A real-world observational study from the French nationwide claims database (SNDS). , 2022, Best practice & research. Clinical obstetrics & gynaecology.
[2] P. Barrière,et al. A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose. , 2022, Journal of gynecology obstetrics and human reproduction.
[3] S. Sunkara,et al. ESHRE guideline: ovarian stimulation for IVF/ICSI† , 2020, Human reproduction open.
[4] Denny Sakkas,et al. Impact of duration and dose of gonadotrophins on IVF outcomes. , 2006, Reproductive biomedicine online.